Coca-Cola Consolidated (COKE) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Net sales rose 3.3% to $1.80B in Q2 2024 and 2.3% to $3.39B in H1, driven by pricing actions despite a 1.2% decline in case volume in Q2 and 0.8% in H1.
Gross profit increased 7% to $716.7M in Q2, with gross margin up 130 bps to 39.9% due to pricing and stable commodity costs.
Net income grew to $172.8M in Q2 (up $50.5M YoY), with adjusted Q2 net income at $192.8M (up $20.3M YoY).
Operating income rose 11% to $259.1M in Q2 and 8% to $474.5M in H1; operating margin improved to 14.0% in H1.
Cash from operations was $437.1M in H1, up from $383.3M YoY, reflecting strong performance.
Financial highlights
Q2 2024 net sales: $1.80B (+3.3% YoY); H1 2024 net sales: $3.39B (+2.3% YoY).
Q2 2024 net income: $172.8M ($18.57/share basic); H1 2024 net income: $338.6M ($36.26/share basic).
Q2 2024 gross profit: $716.7M (+7% YoY); gross margin: 39.9% (+130 bps).
Q2 2024 operating income: $259.1M (+11% YoY); H1 2024: $474.5M (+8% YoY).
Q2 2024 SD&A expenses: $457.6M (+4.5% YoY); H1 2024: $882.7M (+3.1% YoY).
Outlook and guidance
2024 capital expenditures expected between $300M and $350M; $140M–$190M anticipated in H2.
Over the next five years, annual capex is projected at $250M–$300M.
Anticipates annual acquisition-related contingent consideration payments of $50M–$75M for the next five years.
Latest events from Coca-Cola Consolidated
- Key votes include board elections, executive pay approval, and auditor ratification for 2026.COKE
Proxy filing23 Mar 2026 - Virtual meeting to vote on directors, executive pay, and auditor; 78% voting power is concentrated.COKE
Proxy filing23 Mar 2026 - Record 2025 sales and operating income, but net income declined on non-cash adjustments.COKE
Q4 202518 Feb 2026 - Board recommends director slate, auditor, and 10-for-1 stock split; compensation and governance detailed.COKE
Proxy Filing2 Dec 2025 - Board recommends director elections, auditor ratification, and a 10-for-1 stock split.COKE
Proxy Filing2 Dec 2025 - Key votes include director elections, auditor ratification, and a 10-for-1 stock split.COKE
Proxy Filing2 Dec 2025 - Q3 2025 net sales up 6.9%, net income up 23.1%, with strong margins and capital returns.COKE
Q3 202529 Oct 2025 - Q2 2025 delivered higher sales and profit, but first half net income fell on non-cash charges.COKE
Q2 202524 Jul 2025 - Sparkling sales and margins rose in Q3, offsetting lower Still volume and driving profit growth.COKE
Q3 202413 Jun 2025